[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 761
Citations 0
News From the Centers for Disease Control and Prevention
September 17, 2014

Pediatric Ebola Survivors

JAMA. 2014;312(11):1089. doi:10.1001/jama.2014.11157

An analysis of specimens from patients with Ebola virus disease during the 2000-2001 outbreak in Uganda’s Gulu District has shown that pediatric patients who survived had higher levels of certain biomarkers than children and adolescents who died.

Included in the analysis were specimens from 55 pediatric patients and 50 adult patients, all with laboratory-confirmed infection. The results showed that pediatric patients who survived had higher levels of a particular protein—a chemokine called regulated on activation, normal T-cell expressed and secreted (RANTES), also known as CCL5—than those who died. The surviving pediatric patients also had lower levels of plasminogen activator inhibitor 1, soluble intracellular adhesion molecule, and soluble vascular cell adhesion molecule than did those who died (McElroy AK et al. Emerg Infect Dis. doi: 10.3201/eid2010.140430 [published online July 29, 2014]).

First Page Preview View Large
First page PDF preview
First page PDF preview
×